Literature DB >> 9809566

Insular carcinoma: an infrequent subtype of thyroid cancer.

J M Rodriguez1, P Parrilla, A Moreno, J Sola, A Pinero, S Ortiz, T Soria.   

Abstract

BACKGROUND: Insular carcinoma is a little-known thyroid cancer, characterized by the presence of well-defined nidi of small uniform cells with frequent areas of tumor necrosis and microfollicles with thyroglobulin. It was described by Carcangiu in 1984, but its prognosis is not yet clear. STUDY
DESIGN: Six of 335 patients undergoing surgery for thyroid carcinoma had the insular type. We studied age, gender, treatment, histology (tumor size, coexistence of another tumor, extrathyroid spread, vascular invasion, multicentricity, and metastatic adenopathies), TNM, and followup (recurrences, mortality, and survival). These results were compared with those published in the literature.
RESULTS: Insular carcinoma was more common in women (4 of 6), and mean patient age was 32 years. Three patients had metastatic adenopathies. Four patients presented with other thyroid tumors (2 papillary, 1 follicular, and 1 anaplastic) and 2 were simple. Two patients had vascular invasion, and another 2 were extrathyroid. Only 1 case was multicentric. Three recurrences were detected in 2 patients over 50 years old: 1 lymph node at 60 months, 1 pulmonary at 132 months, and the other a bone recurrence at 8 months. Two patients died at 12 and 140 months.
CONCLUSIONS: Insular carcinoma is a special type of thyroid cancer, and the prognosis is poorer than for the classic differentiated thyroid carcinoma.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9809566     DOI: 10.1016/s1072-7515(98)00233-6

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  8 in total

Review 1.  Unusual types of thyroid cancer.

Authors:  K B Ain
Journal:  Rev Endocr Metab Disord       Date:  2000-04       Impact factor: 6.514

2.  Insular carcinomas of the thyroid exhibit poor prognosis and long-term survival in comparison to follicular and papillary T4 carcinomas.

Authors:  Ayman Agha; Gabriel Glockzin; Matthias Woenckhaus; Wolfgang Dietmaier; Igors Iesalnieks; Hans J Schlitt
Journal:  Langenbecks Arch Surg       Date:  2007-01-10       Impact factor: 3.445

3.  Insular carcinoma arising on a background of follicular carcinoma, thyrolipomatosis and amyloid goitre.

Authors:  Tze Ling Loh; Sergios Latis; Rohana Bibi Ali; Hemi Patel
Journal:  BMJ Case Rep       Date:  2017-06-02

4.  Insular thyroid carcinoma in a young Moroccan man: Case report and review of the literature.

Authors:  Wahiba Abdellaoui; Imane Assarrar; Salma Benyakhlef; Abir Tahri; Najoua Messaoudi; Anass Haloui; Siham Rouf; Amal Bennani; Hanane Latrech
Journal:  Ann Med Surg (Lond)       Date:  2022-04-06

5.  Insular carcinoma: infrequent subtype of thyroid cancer with aggressive clinical course.

Authors:  Tzu-Chieh Chao; Jen-Der Lin; Miin-Fu Chen
Journal:  World J Surg       Date:  2004-03-04       Impact factor: 3.352

6.  Significance of an insular component in follicular thyroid carcinoma with distant metastasis at initial presentation.

Authors:  Hiroto Yamashita; Yasushi Noguchi; Shiro Noguchi; Hiroyuki Yamashita; Shinya Uchino; Shinn Watanabe; Takahiro Ogawa; Tsukasa Murakami
Journal:  Endocr Pathol       Date:  2005       Impact factor: 4.056

7.  Propensity score matching analysis of the prognosis for the rare insular subtype of thyroid cancer based on SEER database.

Authors:  Yan Liu; Zeming Liu; Qiuyang Zhao; Teng Hua; Shuqi Chi; Tao Huang; Hongbo Wang
Journal:  Oncotarget       Date:  2017-10-11

8.  Poorly differentiated thyroid carcinoma of childhood and adolescence: a distinct entity characterized by DICER1 mutations.

Authors:  Rebecca D Chernock; Barbara Rivera; Nicla Borrelli; D Ashley Hill; Somayyeh Fahiminiya; Tasha Shah; Anne-Sophie Chong; Barina Aqil; Mitra Mehrad; Thomas J Giordano; Rachel Sheridan; Meilan M Rutter; Louis P Dehner; William D Foulkes; Yuri E Nikiforov
Journal:  Mod Pathol       Date:  2020-01-14       Impact factor: 7.842

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.